Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1991-08-13
1992-06-23
Nutter, Nathan M.
Drug, bio-affecting and body treating compositions
Lymphokine
424 88, 424 89, A61K 3912, A61K 3942
Patent
active
051241480
ABSTRACT:
A method for treating human disease of viral etiology which employs the administration of a pharmaceutically effective amount of a live attenuated virus. Avian paramyxovirus is the virus preferred for use in live attenuated vaccine form, although other viruses of human and nonhuman origin have also been shown to be effective. The administration of a pharmaceutically effective amount of avian paramyxovirus and avian rotavirus vacciine has been shown to be efficacious in the treatment of Herpes virus infections, hepatitis-A, some cancers, aphthous stomatitis, acquired immune deficiency syndrome (AIDS) and polyarteritis nodosa.
REFERENCES:
patent: 3548054 (1970-12-01), Bowen
patent: 3577525 (1971-05-01), Baker
patent: 4053582 (1977-10-01), Stickl
patent: 4108983 (1978-08-01), Wallack
Csatary et al., "Interference Between Human Hepatitis A Virus and An Attenuated Apathogenic Avian Virus", Acta Microbiologica Hungarica 31(2)153-58 (1984).
Csatary Laszlo K.
Massey Richard J.
Nutter Nathan M.
United Cancer Research Institute
LandOfFree
Method for treating viral diseases with attenuated virus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating viral diseases with attenuated virus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating viral diseases with attenuated virus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-931757